Saw Dx Limited

#SC444739 Active

SAW Dx is an emerging point of care diagnostic (POC) device design and manufacturing venture focused on exploiting Acoustic-Flow technology based on the use of surface acoustic waves technology developed in the laboratory of Professor Jon Cooper, University of Glasgow. The Acoustic-Flow technology utilises the interaction of Surface Acoustic Waves (SAW) with a patient sample to drive a diagnostic test. The interactions are controlled by microstructures patterned on the surface of disposable chips, to shape sound in particular ways in a frequency dependant manner. Functions possible include fluid movement, mixing, particle patterning, enrichment, opening cells to release DNA and temperature cycling of a sample. Acoustic-Flow technology means that samples can be processed on-chip (no preprocessing required) and complex microfluidics are avoided. The SAW Dx business model is based on providing product and technology solutions to life sciences and diagnostics companies seeking to enhance their diagnostic product offerings through innovative point of care use.

Founded: 11 Mar 2013
Industries:
74909 - Other professional, scientific and technical activities n.e.c.
Website: sawdx.com
Location: Glasgow

Products & Services

• biotechnology
• medical device

People

Officers
3
Shareholders
7
Controllers (PSC)
1
Jonathan Cooper
Director • British • Lives in Scotland • Born in Jun 1961
Iain David Miller
Director • British • Lives in England • Born in May 1964
Steven Peter Beaumont
Director • British • Lives in United Kingdom • Born in Feb 1952

Registered Office Address

11 The Square University Avenue

Glasgow

G12 8QQ

Basic Information

LTD
11 Mar 2013
SCOTLAND
No
29 Sept 2020

Industry Classification

74909

Company Attributes

No
No
No
N/A

Summary

9
Officers
1
PSCs
0
Filings